Literature DB >> 29802976

10-year nationwide trends of the incidence, prevalence, and adverse outcomes of non-valvular atrial fibrillation nationwide health insurance data covering the entire Korean population.

Daehoon Kim1, Pil-Sung Yang2, Eunsun Jang1, Hee Tae Yu1, Tae-Hoon Kim1, Jae-Sun Uhm1, Jong-Youn Kim1, Hui-Nam Pak1, Moon-Hyoung Lee1, Boyoung Joung3, Gregory Yh Lip4.   

Abstract

BACKGROUND: Most data on the clinical epidemiology of atrial fibrillation (AF) are reported from Western populations, and data for Asians are limited. We aimed to investigate the 10-year trends of the prevalence and incidence of non-valvular AF and provide prevalence projections till 2060 in Korea. We also investigated the annual risks of adverse outcomes among patients with AF.
METHODS: Using the Korean National Health Insurance Service database involving the entire Korean population, a total of 679,416 adults with newly diagnosed AF were identified from 2006 to 2015. The incidence and prevalence of AF and risk of adverse outcomes following AF onset were assessed.
RESULTS: The prevalence of AF progressively increased by 2.10-fold from 0.73% in 2006 to 1.53% in 2015. The trend of its incidence was flat with a 10-year overall incidence of 1.77 per 1,000 person-years. The prevalence of AF is expected to reach 5.81% (2,290,591 patients with AF) in 2060. For a decade, the risk of all-cause mortality following AF declined by 30% (adjusted hazard ratio [HR]: 0.70, 95% confidence interval [CI]: 0.68-0.72), heart failure by 52% (adjusted HR: 0.48, 95% CI: 0.44-0.51), and ischemic stroke by 9% (adjusted HR: 0.91, 95% CI: 0.88-0.93).
CONCLUSIONS: The burden of AF among Asian patients is increasing. Although the overall risks of cardiovascular events and death following AF onset have decreased over a decade, the event rates are still high. Optimized management of any associated comorbidities should be part of the holistic management approach for patients with AF.
Copyright © 2018. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2018        PMID: 29802976     DOI: 10.1016/j.ahj.2018.04.017

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  34 in total

1.  Application of the simple atrial fibrillation better care pathway for integrated care management in frail patients with atrial fibrillation: A nationwide cohort study.

Authors:  Pil-Sung Yang; Jung-Hoon Sung; Eunsun Jang; Hee Tae Yu; Tae-Hoon Kim; Gregory Y H Lip; Boyoung Joung
Journal:  J Arrhythm       Date:  2020-06-05

2.  Computational Modeling for Antiarrhythmic Drugs for Atrial Fibrillation According to Genotype.

Authors:  Inseok Hwang; Je-Wook Park; Oh-Seok Kwon; Byounghyun Lim; Myunghee Hong; Min Kim; Hee-Tae Yu; Tae-Hoon Kim; Jae-Sun Uhm; Boyoung Joung; Moon-Hyoung Lee; Hui-Nam Pak
Journal:  Front Physiol       Date:  2021-05-13       Impact factor: 4.566

3.  Label Adherence of Direct Oral Anticoagulants Dosing and Clinical Outcomes in Patients With Atrial Fibrillation.

Authors:  Hee Tae Yu; Pil-Sung Yang; Eunsun Jang; Tae-Hoon Kim; Jae-Sun Uhm; Jong-Youn Kim; Hui-Nam Pak; Moon-Hyoung Lee; Gregory Y H Lip; Boyoung Joung
Journal:  J Am Heart Assoc       Date:  2020-06-04       Impact factor: 5.501

Review 4.  2018 Korean Guideline of Atrial Fibrillation Management.

Authors:  Boyoung Joung; Jung Myung Lee; Ki Hong Lee; Tae Hoon Kim; Eue Keun Choi; Woo Hyun Lim; Ki Woon Kang; Jaemin Shim; Hong Euy Lim; Junbeom Park; So Ryoung Lee; Young Soo Lee; Jin Bae Kim
Journal:  Korean Circ J       Date:  2018-12       Impact factor: 3.243

5.  C2 HEST Score and Prediction of Incident Atrial Fibrillation in Poststroke Patients: A French Nationwide Study.

Authors:  Yan-Guang Li; Arnaud Bisson; Alexandre Bodin; Julien Herbert; Leslie Grammatico-Guillon; Boyoung Joung; Yu-Tang Wang; Gregory Y H Lip; Laurent Fauchier
Journal:  J Am Heart Assoc       Date:  2019-06-25       Impact factor: 5.501

6.  Social Inequalities of Oral Anticoagulation after the Introduction of Non-Vitamin K Antagonists in Patients with Atrial Fibrillation.

Authors:  Hee Tae Yu; Pil Sung Yang; Jinseub Hwang; Soorack Ryu; Eunsun Jang; Tae Hoon Kim; Jae Sun Uhm; Jong Youn Kim; Hui Nam Pak; Moon Hyoung Lee; Gregory Y H Lip; Boyoung Joung
Journal:  Korean Circ J       Date:  2020-03       Impact factor: 3.243

7.  Associations of hypertension burden on subsequent dementia: a population-based cohort study.

Authors:  Hyunjean Jung; Pil-Sung Yang; Daehoon Kim; Eunsun Jang; Hee Tae Yu; Tae-Hoon Kim; Jung-Hoon Sung; Hui-Nam Pak; Moon-Hyoung Lee; Gregory Y H Lip; Boyoung Joung
Journal:  Sci Rep       Date:  2021-06-10       Impact factor: 4.379

8.  A prospective, observational study of rivaroxaban for stroke prevention in atrial fibrillation: the XANAP Korea.

Authors:  Jaemin Shim; Young Keun On; Sun U Kwon; Gi-Byoung Nam; Moon-Hyoung Lee; Hyung-Wook Park; Keun-Sik Hong; Nam-Ho Kim; Pierre Amarenco; Seung-Woon Rha; Dong-Gu Shin; Joung-Ho Rha; Young-Hoon Kim
Journal:  Korean J Intern Med       Date:  2021-06-11       Impact factor: 2.884

9.  Left Atrial Wall Stress and the Long-Term Outcome of Catheter Ablation of Atrial Fibrillation: An Artificial Intelligence-Based Prediction of Atrial Wall Stress.

Authors:  Jae-Hyuk Lee; Oh-Seok Kwon; Jaemin Shim; Jisu Lee; Hee-Jin Han; Hee Tae Yu; Tae-Hoon Kim; Jae-Sun Uhm; Boyoung Joung; Moon-Hyoung Lee; Young-Hoon Kim; Hui-Nam Pak
Journal:  Front Physiol       Date:  2021-07-02       Impact factor: 4.566

10.  Efficacy and Safety of Outpatient Clinic-based Elective External Electrical Cardioversion in Patients with Atrial Fibrillation.

Authors:  Nguyen Khac Le Son; Je Wook Park; Min Kim; Song Yi Yang; Hee Tae Yu; Tae Hoon Kim; Jae Sun Uhm; Boyoung Joung; Moon Hyoung Lee; Hui Nam Pak
Journal:  Korean Circ J       Date:  2020-03-12       Impact factor: 3.243

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.